ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunosuppression"

  • 2020 American Transplant Congress

    Comparison of 4 vs 14 Days Early Steroid Withdrawal in Kidney Transplant Recipients

    O. Adebiyi, J. Chen, B. Brady, S. Mietz, T. Taber, D. Mishler, M. Yaqub, W. Goggins, A. Sharfuddin

    Indiana University, Indianapolis, IN

    *Purpose: The optimal duration, as well as the dose of the initial steroid use, is not known as it varies widely among institutions that have…
  • 2020 American Transplant Congress

    A Two-Step Cell-Based Assay Predicts Immunosuppression-Related Adverse Events in Kidney Transplant Recipients

    F. Bouchard-Boivin, O. Désy, S. Béland, S. De Serres

    Transplantation Unit, Renal Division, Medecine Department, Laval University, Québec, QC, Canada

    *Purpose: No clinical tool is available to dynamically access immunosuppression status, which results in serious, often life-threatening adverse effects of immunosuppressants. We recently validated that…
  • 2020 American Transplant Congress

    A Single Centre Experience of Conversion from Immediate Release Tacrolimus (IR-tac) to Extended Release Envarsus

    S. Chong1, E. Kent2, C. Beligaswatta2, P. Gudka2, C. Magee2, M. Harber2, R. Motallebzadeh1, G. Jones2

    1Centre for Transplantation, Department of Renal Medicine, University College London & Royal Free London NHS Foundation Trust​, London, United Kingdom, 2Department of Renal Medicine, University College London & Royal Free London NHS Foundation Trust​, London, United Kingdom

    *Purpose: IR-Tac is first line maintenance immunosuppression in kidney transplant recipients. Its rapid absorption of 1-2 hours can lead to peak levels (Tmax ) within…
  • 2020 American Transplant Congress

    The Importance of Annual Medicare Part D Plan Evaluation in Heart Transplantation

    L. M. Lourenco

    Pharmacy Services, University of Chicago Medicine, Chicago, IL

    *Purpose: The Medicare open enrollment period is from Oct 15 to Dec 7, annually. The purpose of this project was to objectively measure the benefit…
  • 2020 American Transplant Congress

    Efficacy and Possible Risk of De Novo Use of Everolimus for Primary Kidney Transplantation

    S. Narumi1, Y. Watarai1, N. Goto2, T. Hiramtsu1, M. Okada1, K. Futamura2, T. Tomosugi1, A. Kanda2, T. Kobayashi3

    1Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya City, Aichi Prefecture, Japan, 2Transplant Nephrology, Nagoya Daini Red Cross Hospital, Nagoya City, Aichi Prefecture, Japan, 3Transplant Surgery, Aichi Medical University School of Medicine, Nagakute City, Aichi Prefecture, Japan

    *Purpose: Transplant outcome and protocol stay rate of everolimus were investigated to clarify efficacy and risk of everolimus based regimens at a single institute.*Methods: During…
  • 2020 American Transplant Congress

    Case Series of Belatacept for Calcineurin Inhibitor Sparing after Lung Transplantation

    H. Patel, C. R. Ensor, R. D. Davis, L. Bogar, D. Colella, M. Kildea, J. Kim, A. Satterthwaite, D. Ventura, C. Gries

    AdventHealth, Orlando, FL

    *Purpose: Belatacept is a recombinant soluble fusion protein which selectively blocks T-cell co-stimulation. It received initial FDA approval for prophylaxis of organ rejection in Epstein-Barr…
  • 2020 American Transplant Congress

    The Role of mTOR Inhibitors on Cardiovascular Aging in Renal Transplanted Patients with Chronic Graft Dysfunction

    G. Castellano1, B. Infante1, P. Pontrelli1, R. Franzin1, F. Rascio1, C. Prisciandaro2, L. Gesualdo1, N. Coviello3, G. Grandaliano3, G. Stallone3

    1Emergency and Organ Transplantation, University of Bari, Bari, Italy, 2University of Foggia, Foggia, Italy, 3Emergency and Organ Transplantation, University of Foggia, Foggia, Italy

    *Purpose: Chronic Kidney Disease (CKD) is strongly associated with increased circulatory complications that can lead to accelerated cardiovascular aging. During CKD, persistent oxidative stress triggered…
  • 2020 American Transplant Congress

    Efficacy of Photobiomodulation Therapy Combined with Short-Term Immunosuppressants Prolonged Allotransplant Survival in a Rodent Hind-Limb Model

    Y. Kuo1, C. Chen2, R. Chen2, Y. Li2

    1Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 2Division of Plastic Surgery, Department of Surgery,, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

    *Purpose: Photobiomodulation has been applied for accelerating the skeletal muscle repair process. Our formal study demonstrated vitamin D could be involved in allograft survival and…
  • 2020 American Transplant Congress

    Treg Lymphotoxin Signals Promote Cancer Metastatic Migration: Mechanisms for Treg-Cancer Interaction

    W. Piao1, R. Oakes2, C. Paluskievicz1, Y. Xiong1, L. Li1, V. Saxena1, M. WillsonShirkey1, C. Jewell2, J. Bromberg1

    1Surgery, U of Maryland, Baltimore, MD, 2U of Maryland, College Park, MD

    *Purpose: Immune suppressive therapy can be complicated by malignancy. Regulatory T cells (Treg) control immune tolerance for graft survival but cause to immune suppression in…
  • 2020 American Transplant Congress

    Autophagy-Lysosome Inhibitor Chloroquine Prevents CTLA-4 Degradation of T Cells and Attenuates Acute Rejection in Murine Skin and Heart Transplantation

    J. Wu

    Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    *Purpose: The immune checkpoint cytotoxic T lymphocyte antigen-4 (CTLA-4), which was induced upon T cell activation but degraded quickly, has been targeted in the clinical…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 138
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences